Peptide comparisons
Head-to-head breakdowns of commonly confused or commonly paired peptides.
BPC-157 vs TB-500
The two most-discussed recovery peptides — one acts locally on the gut–brain axis and growth factors, the other systemically on actin and cell migration.
CJC-1295 vs Sermorelin
Two GHRH analogs separated mainly by half-life: Sermorelin is short-acting, CJC-1295 was engineered to last far longer.
Ipamorelin vs GHRP-6
Two ghrelin-mimetic GHRPs with very different selectivity profiles for appetite and cortisol.
CJC-1295 vs Ipamorelin
Not really rivals — a GHRH analog and a GHRP studied as a synergistic pair.
GHRP-2 vs GHRP-6
The two classic GHRPs, compared on potency, appetite stimulation, and cortisol.
Sermorelin vs Tesamorelin
Two GHRH-based compounds — one a short fragment, the other a stabilised analog with an FDA approval.
Ipamorelin vs Hexarelin
Selectivity versus potency: Hexarelin is among the strongest GHRPs but less clean than Ipamorelin.
Semaglutide vs Tirzepatide
The headline metabolic comparison: a GLP-1 agonist versus a dual GLP-1/GIP agonist.